| Literature DB >> 35923327 |
Abstract
The increasing use of metal oxide-based nanoparticles (MNPs) and their release into the environment cast concerns about their environmental impacts. Massive efforts have been focused on environmental behaviours and ecotoxicities to figure out the potential threats posed by MNPs. This review systematically summarises and re-analyses published data about the MNP interactions and transformation processes in freshwater and the toxicological effects of MNPs on invertebrates. A case study was conducted through meta-analysis to examine the impacts of silver nanoparticle exposure to freshwater invertebrates. The conclusions categorized the current understanding of the outcome and ecotoxicity of MNPs in freshwater. The adverse outcome pathway (AOP) is recommended for environmental risk assessment as it provides a rapid and accurate risk assessment of an increasing number of novel compounds consuming fewer resources and animal tests. Invertebrates contribute significantly towards developing robust AOPs thanks to a shorter life cycle, allowing chronic and complete life cycle toxicity tests. This journal is © The Royal Society of Chemistry.Entities:
Year: 2022 PMID: 35923327 PMCID: PMC9282172 DOI: 10.1039/d2en00052k
Source DB: PubMed Journal: Environ Sci Nano
Fig. 1The schematic diagram illustrates the overview of the environmental transformations and the biological fate of transformed MNPs in freshwater environments. MNPs may undergo physical, chemical, and biological transformation processes. The MNP transformation differs mainly according to their intrinsic properties (e.g., size, surface charge, coating and concentration) and environmental conditions (e.g., pH, IS, NOM, related values are referenced from ref. 21, 56 and 64). The transformed MNPs may accumulate in some typical freshwater invertebrates, such as filter-feeding bivalve molluscs, gastropods molluscs and crustacean arthropods, and contribute to the trophic transfer of MNPs.
Overview of the toxic effects of MNPs on bivalves according to species, and type of MNPs
| Species | MNPs | Time | End points | Ref. | ||
|---|---|---|---|---|---|---|
| Type | Size (nm) | Conc. | ||||
|
| AgNPs | 20 | 1, 10, 100 μg g−1 | 14 d | ↑GSH (HP, F, gonad, DG), ↑SOD (HP), ↑POD (F), ↓CAT (HP, gonad) |
|
|
| AgNPs | 8–19 | 12.5, 25 and 50 mg L−1 | 6 d | ↑MDA, ↓GSH, ↓CAT, ↑NO concentration |
|
|
| AgNPs | 27.66 ± 0.80 | 0.1, 0.5, 2 mg L−1 | 14 d | ↑SOD, ↑CAT, ↑GPx in the mediate concentration ↑GSH ↑GST ↓GPx in the highest concentration, ↓ammonia excretion and ↓feeding rates |
|
|
| AgNPs | 80 | 0.8, 4 and 20 μg L−1 | 48 h | ↓HSP72 protein, ↑digestive gland lipid peroxidation, ↑metallothioneins, ↑DNA strand breaks |
|
|
| AgNPs | 80 | 0.8, 4 and 20 μg L−1 | 48 h | ↑Lipid peroxidation, ↑phagocytosis activity, ↓cytotoxicity activity |
|
|
| AgNPs | 15 | 5, 25, 50, 100 and 500 μg L−1 | 28 d | ↓Reproduction, ↑ROS, ↑CAT, ↓GPx, ↑GST, ↓Na+/K+-ATPase activity |
|
|
| AgNPs | 10–50 | 20, 30, 40 and 50 μg mL−1 | 24 h | ↑Mortality and abnormal swimming behavior |
|
|
| AgNPs | 70–80 | 10 and 50 μg L−1 | 48 h | ↓PK-LDH, ↓F-actin, and ↓protein-ubiquitin (UB) |
|
|
| Ag/SNCs | 10–25 | 12.5, 25 and 50 mg L−1 | 6 d | ↑MDA, ↑NO concentration, ↓GSH, ↓CAT |
|
|
| AuNPs | 10 | 0.5, 1,5,12, 24 ppm | 4 h | ↑Endocytosis gene expression, ↑oxidative stress gene expression, ↑immune system gene expression, ↑apoptosis gene expression |
|
|
| Au/TiO2NPs | 10 | 100 and 200 μg L−1 | 7 d | ↓CAT, ↑GST, ↓AChE, ↑H2O2 |
|
|
| Al2O3NPs | 40 | 0, 1, 3, 9 mg L−1 | 14 d | ↓SOD, ↓CAT, ↑GST, ↑GPx |
|
|
| CeO2NPs | 20–25 | 10, 100 μg L−1 | 6 d | ↑DNA tail length, ↑Casp-3 activity in the highest concentration |
|
|
| CeO2 NPs | 3–4 | 1 mg L−1 | 21 d | ↓piGST mRNA expression, ↑hemocyte lysosomal system size, ↓CAT, ↓GST, ↓[LOOH] |
|
|
| CeO2NPs | 1385 (dH) | 100 μg L−1 | 14 d | ↑ETS, ↓ROS, ↓SOD, ↓CAT, ↓GPx, ↓GST, |
|
|
| CeO2NPs | 3 ± 1 | 10 and 100 μg L−1 | 4 d | ↓CAT, ↑GST, ↓haemolymph [Na+] |
|
|
| CuONPs | 79 ± 10 | 2, 10 and 50 μg L−1 | 96 h | ↑Poly-ubiquitinylated protein, ↓LPO, ↓DNA strand breaks, ↓AChE |
|
|
| CuONPs | 34 ± 4.5 | 0.5, 1, 5 mg L−1 | 14 d | ↓Hemocyte count, ↓phagocytic efficacy, ↑SOD↓nitric oxide generation, ↓ total protein content in hemocytes, ↓CAT, ↓PhO |
|
|
| CuONPs | 40 | 0, 1, 3, 9 mg L−1 | 14 d | ↓SOD, ↓CAT, ↑GST, ↑GPx |
|
|
| TiO2NPs | 20 | 1, 5, 10 and 50 μg mL−1 | 4 h | ↓SOD, ↓CAT, ↓protein sulfhydryl content |
|
|
| TiO2NPs | 21 | 1, 5, 10 and 50 μg mL−1 | 4 h | ↑Tail DNA |
|
|
| TiO2NPs | <150 | 1.25 μM | 14 d | ↓ROS, ↓PhO ↑SOD, ↑lipofuscin accumulation, ↑TBAR, ↑GSH, ↑GSSG, ↑GSH/GSSG, ↑lactate/pyruvate, ↑ALP, ↑cathepsin D total activity, ↑cathepsin D free (outside lysosome) activity, ↓lysosomal membrane stability |
|
|
| TiO2NPs | 21 | 0, 1, 3, 9 mg L−1 | 14 d | ↓SOD, ↓CAT, ↑GST, ↑GPx |
|
|
| ZnONPs | 50–100 | 3.1 μM | 14 d | ↑Glycogen, ↓glucose, ↓lipids, ↑pyruvate, ↓lactate, ↓lactate/pyruvate, ↑ATP |
|
Glutathione (GSH), superoxide dismutase (SOD), POD catalase activity (CAT), malondialdehyde (MDA), glutathione peroxidase (GPx), glutathione-S-transferase (GST), reactive oxygen species (ROS) production, acetylhydrolase (AChE), hydrogen peroxide (H2O2), lipid hydroperoxide (LOOH), mitochondrial electron transport system (ETS), lactoperoxidase (LPO), alkaline phosphatase (ALP), phenoloxidase-like (PhO) activity, nitric oxide (NO), adenosine triphosphate (ATP), pyruvate kinase-lactate dehydrogenase (PK-LDH).
Overview of the toxic effects of MNPs to gastropods according to species, and type of MNPs
| Species | MNPs | Time | End points | Ref. | ||
|---|---|---|---|---|---|---|
| Type | Size (nm) | Conc. | ||||
|
| AgNPs | 20, 40 and 80 | 1, 10 and 100 mg g−1 | 14 d | ↑Oxidative stress, ↑GSH, ↑SOD, ↑POD, ↑CAT |
|
|
| AgNPs | — | 3–100 mg mL−1 | 24 h | Molluscicide, cercaricide, and anti-parasitic effect |
|
|
| AgNPs | 20–60 | 20 and 60 mg L−1 | 14 d | ↑Bioaccumulation on biofilm. NP impacts on ecological receptors and food chains |
|
|
| AgNPs | 115.17 ± 55.57 | 1.0, 2.5, and 5.0 mg L−1 | 30 d | ↓Reproduction rate; ↓egg per egg masses, ↓egg masses production per snail |
|
|
| AgNPs | 10.3 ± 3.4 | 25 nM L−1 | 24 h | The presence humic acid ↑uptake AgNPs PVP in contrast with cysteine but did not eliminate uptake of 25 nM L−1 |
|
| 12.8 ± 4.4 | ||||||
|
| AgNPs | 100 | 5, 10 and 50 mg L−1 | 72 h | ↑Memory formation (10 mg L−1). Blocks memory formation (50 mg L−1). Memory recall is context-specific, thus snails trained in AgNPs do not |
|
|
| AgNPs | 24–190 | 0.001, 0.01, 0.1, 1, 10, 100 mg L−1 | 96 h and 28 d | ↑Mortality; ↓egg production; ↓snail size at first reproduction, ↑behavior changes |
|
|
| AgNPs | 15 | 0.10–1000 mg L−1 | 28 d | ↓Reproduction. AgNPs in low concentrations can modulate 17a-ethynylestradiol activity |
|
|
| AgNPs | 13 | 100 μg g−1 | 2 wk | ↓Growth, ↓reproduction |
|
|
| AgNPs | 32.4 ± 2.6 | 4.01, 12.03 and 24.05 mg L−1 | 96 h | ↑Oxidative stress; ↑CAT; ↓GSH; ↓GST; ↓GPx; ↑MDA; ↑DNA damage |
|
|
| AuNPs | — | 100–200 mg mL−1 | 24 h | Modulation and prevention of the infectivity of cercariae and miracidia |
|
|
| CuONPs | 41.6 ± 4.6 | 180 mg g−1 | 28 d | ↑Oxidative stress, ↑SOD, ↑CAT, ↑GST, ↑MDA |
|
|
| CuONPs | 6 ± 1 | 0, 30, 60, 120 and 240 mg g−1 | 8 wk | ↓Growth rate, ↓feeding rate, ↓reproduction, and ↑bioaccumulation |
|
|
| CeO2NPs | 25 | 60 mg L−1 | 15 d | High bioaccumulation factor. No mortality |
|
|
| CuONPs | 7 | Db: 4–50 mmol g1 and 50–175 nmol g−1 | 3–5 h (Db) | Bioaccumulation associated to toxicity. Toxicity: Db exposures > Wb exposure |
|
| Wb: 4–16 nM to 31 mM | 24 (Wb) | |||||
|
| CuONPs | 43.5 ± 1.5 | 7 and 21 mg L−1 | 5 d | ↑Oxidative stress; ↓GSH, ↓GPx, ↓GST. ↑LPO, ↑SOD (lower concentration, 1 d); ↓SOD (5 d). ↓CAT (2 d); ↑CAT (5 d, lower concentration). DNA damage mediated by oxidative stress |
|
|
| CuONPs | 10 | 180 μg g−1 | 7, 14, and 28 d | ↑SOD, ↑CAT, and GST↑ (7 d), ↓SOD, ↓CAT, and ↓GST (>14 d) |
|
|
| CdTeNPs | 3 | 50, 100, 200, 400 nM | 24 h | Malformations and mortality of embryos and adult snails depending on the concentration. ↑Cytotoxicity (hemocyte apoptosis) |
|
|
| γ-Fe2O3NPs | 5.7 | 1.0, 10, 100 mg L−1 | 10 d | No effect on fecundity, fertility, mortality of adults, similar hatching rate, no malformation in embryos |
|
| 28 d | ||||||
|
| SiO2NPs | 80 | 50, 100, 200, 400, 600, 800, 1000, 1200 ppm | 3, 6, 12, 24, 36 h | Non-embryonated egg masses (1400 ppm/24 h), embryonated pre-hatched one (1450 ppm/12 h). |
|
|
| TiO2NPs | 11.6 ± 2.4 | 5 and 25 mg kg−1 | 21 d | ↑LPO, ↑PC, ↓Na |
|
|
| TiO2NPs | 5–10 | 1818.2 mg L−1 | 17 d | Bioaccumulation through trophic transfer during plant consumption. ↑Uptake and bioaccumulation |
|
|
| TiO2NPs | 10–20 | 2 and 6 mg L−1 | 14 d | Biomagnified through aquatic food chains. NPs show greater movement in the sediment than in the water in a simplified food chain. ↑Bioaccumulation in the semistatic exposition |
|
|
| TiO2NPs | 34.1 ± 2.7 | 9 and 28 mg mL−1 | 7 d | ↓GSH, ↓GST, ↑MDA, ↓SOD, ↓CAT (9 mg mL), ↑CAT (28 mg mL). |
|
|
| TiO2NPs | 34.1 ± 2.7 | 28, 56, 84 mg mL−1 | 96 h | ↓GSH, ↓GST, ↑Oxidative stress, ↑MDA |
|
|
| ZnONPs | 22 | 10, 21 and 32 mg mL−1 | 96 h | ↓GSH, ↓GST, ↓GPx, ↑MDA, ↑CAT. genotoxicity mediated by oxidative stress |
|
|
| ZnONPs | 17.5 | 25–600 mg mL−1 | 24 h | ↑MDA, ↑NO, ↓GSH, ↓GST, ↓SOD, ↓PTN, ↓Alb,↑Ch, ↑AST, ↑ALT, ↑ALP,↑CAT |
|
| 21 d | ||||||
Overview of the toxic effects of MNPs to crustacean according to species, and type of MNPs
| Species | MNPs | Time | End points | Ref. | ||
|---|---|---|---|---|---|---|
| Type | Size (nm) | Conc. | ||||
|
| AgNPs | 18.2 ± 10.1 | 0.5, 1, 3, 5, 10 μg L−1 | 48 h | ↑AChE, ↓ROS, ↑GSH, ↑CAT |
|
|
| AgNPs | 6.3–8.4 | 50, 100, 200, 300 μg L−1 | 21 d | ↑Mortality (dose–effect) |
|
|
| AgNPs | 20, 23 and 27 | 1, 3 μg L−1 | 72 h | ↓Haemolymph osmolality, no significant in antioxidant responses, defense mechanisms, cellular damage, energy reserves and ventilatory activity |
|
|
| AgNPs | 40 and 110 | 2 μg L−1 | 24 h | Citrate-coated AgNPs were more toxic than PVP-coated AgNPs, and 40 nm AgNPs were more toxic than 110 nm AgNPs |
|
|
| AgNPs | 40 | 0, 0.5, 5 μg L−1 | 15 d | ↑Catalse and chitinase gene expression, ↑digestive lysosomal system, ↓locomotor activity |
|
|
| AgNPs | 20, 40 and 80 | 1, 2, 4, 8, 10 μg L−1 | 72 h | ↑CuZnSOD gene expression |
|
|
| AgNPs | 9.8 ± 0.8 | 0.1, 0.5, 1, 2, 5 μg L−1 | 21 d | ↑Time to first brood, ↓number of offspring per female, ↓survival |
|
|
| AgNPs | 9.8 ± 0.8 | 0.2, 0.5 μg L−1 | 21 d | ↓Reproduction rate |
|
|
| AgNPs | — | 4, 5, 10, 15 and 20 μg ml−1 | 24 h | ↑Mortality rate, ↑DNA damage |
|
|
| AgNPs | 20 and 40 | 0.011 and 0.022 mg L−1 | 48 h | ↓AChE, ↓SOD, ↑CAT, ↑GST, ↓trypsin activity, ↓β-galactosidase activity, ↑phosphatase activity |
|
|
| AgNPs | 10.56 ± 2.27, 9.27 ± 1.29, 13.68 ± 0.76 | 30 μg L−1 | 28 d | ↑TBARS, ↑CAT |
|
|
| AgNPs | 23 ± 2 | 10, 20 40 and 50 μg L−1 | 24 h | ↑Mortality, abnormal swimming, ↓heart rate, ↓thoracic limb movement |
|
|
| AgNPs | 65 | 3.5, 8.1, 0.43, 1.05 μg L−1 | 24 h | ↓Sensory development, damage repair genes |
|
|
| AgNPs | 5–50 | 10, 20, 30, 40 and 50 μg L−1 | 48 h | ↓Survival |
|
|
| AgNPs | — | 10, 50, 150, 250, 350, 450, 550 and 1000 mg L−1 | 48 h | ↑Immobilization |
|
|
| Sn-AgNPs | 10–50 | 1, 2, 5, 10, 20, 30, 40 and 50 μg ml−1 | 24 h | ↑Mortality, abnormal swimming behaviour |
|
|
| Al2O3NP | <50 | 3.12, 6.25, 12.5 and 25 mg L−1 | 21 d | ↓Survivors, ↓body length, ↓age at first brood, ↓neonates per surviving adult, ↑ROS, ↑CAT, ↓SOD, ↓GSH, ↑MDA, ↓average swimming distance of neonates (48 h) |
|
|
| CeO2NPs | 5 | 10 and 100 μg L−1 | 48 h | ↓CAT (ceria@chitosan type), ↓GST (ceria@alginate type), ↑ROS (ceria@alginate type), ↑swimming activity, ↑swimming velocity (ceria@alginate type) |
|
|
| CuONPs | 45 ± 3 | 0.1, 1, 5, 10 and 25 mg L−1 | 24 h | ↓Number of motile counts |
|
|
| CuONPs | <50 | 0.5, 1, 1.5, 2, 2.5 and 3 mg L−1 | 120 h | ↓Survival |
|
|
| CuONPs | <50 | 0.07 and 15 mg L−1 | 14 d | ↑Mortality (Wb), ↓average number of neonates produced per adult at high concentration (Fb), ↓total number of broods produced per adult (Wb) at the high concentration, ↓total number of broods produced per adult (Fb) at the low concentration |
|
|
| CuONPs | 110.34 ± 56.58, 38.27 ± 23.05 | 0.01, 0.05, 0.1, 0.5, 1, 2, 3, 5, 25, 50, 75 and 100 mg L−1 | 48 h | ↓Survival |
|
|
| SiO2NPs, Fe3O4 NPs | 20–30, <20 | 5, 50, 100, 250, and 250 mg L−1 | 96 h | ↑Mortality rate |
|
|
| TiO2NPs | 29 ± 8 | 1, 10, 100 ppm | 48 h | ↑Mortality, ↑swimming distance |
|
|
| TiO2NPs | <25 | 0.1 and 1 mg L−1 | 2 d | No significant ROS increase and MT induction. |
|
|
| TiO2NPs | 9.5 ± 1 (anatase), 26 ± 3 (rod-shaped rutile) | 025, 0.5, 0.75, 1, 1.25, 1.5, and 1.75 toxic unit | 48 h | ↑Mortality rate |
|
|
| TiO2NPs | <25 | 1 and 10 mg L−1 | 96 h | ↓Growth rate |
|
|
| TiO2NPs | <25 | 7, 75, and 750 mg L−1 | 24 h | ↓CAT, ↓AP, ↓SOD |
|
|
| ZnONPs | 20–40 | 0.009, 0.014, 0.027, 0.058, 0.131 mg L−1 | 21 d | ↓Average brood size, ↑time to first brood, ↓broods per female |
|
|
| ZnONPs | 61 ± 12 | 0.06 mg L−1 | 24 h | ↓Na+ /K+ ATPase, ↓RNA-binding protein, ↓rRNA methyltransferase, ↓signal recognition particle receptor, ↓signal peptidase |
|
|
| ZnONPs | 10–30 | 0.2, 1, 5, 10, 25, 50 ppm | 72 h | ↓Alive account |
|
|
| ZnONPs | <50 | 0.1 and 0.3 mg L−1 | 21 d | ↓Survival probability |
|
|
| ZnONPs | 63 ± 11 | 0.1 mg L−1 | 14 d | ↓Survival, ↓body length and embryo numbers of the first brood, ↓SOD, ↓GST, ↓CAT, ↓MDA |
|
Fig. 2Overview of MNP bioaccumulation with three major species of freshwater organisms and the mechanisms of cell damage by MNPs (damage of membranes, DNA and mitochondria; lysosome dysfunction, generation of reactive oxygen species, ROS, disturbance of protein functions).
Fig. 3Flow chart of the study selection process.
Fig. 4MNP research areas sorted by the number of articles published.
Fig. 5Flow diagram illustrating an AOP. The putative MIEs, KEs and AOs are illustrated based on the published research on the toxic mechanisms of nanomaterials (such as ZnONPs, CuONPs and AgNPs) in organisms. The cellular response (including oxidative stress, DNA damage and gene expression) and organ damage (i.e. physiology response, organic function and histopathology) are essential integrators of multiple upstream KEs. Upon the above effects, MNPs could eventually lead to sequential higher-order effects producing adverse outcomes (i.e. influencing the individual development, reproductive output and offspring viability). If NPs diminish the fitness of organisms, the population dynamics might be affected and possibly affect ecosystem stability and functioning.